Skip to the beginning of the images gallery

Candida BCG HiVeg™ Agar Base

0 Review

As low as ₹6,962.00

Availability: In stock

Only %1 left

SKU:

MV355

For primary isolation and identification of Candida species.

Description

Intended Use

Recommended for primary isolation and identification of Candida species.

Composition**

Ingredients	g/L
HiVeg™ peptone	10.000
Yeast extract	1.000
Dextrose (Glucose)	40.000
Bromocresol green	0.020
Agar	15.000
Final pH (at 25°C)	6.1±0.2

**Formula adjusted, standardized to suit performance parameters

Directions

Suspend 66.02 grams in 1000 ml purified / distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes. Cool to 45-50°C and add sterile neomycin to a concentration of 500 µg/ml of medium. Mix well before pouring into sterile Petri plates.

Principle And Interpretation

Candida albicans is most frequently isolated from clinical specimens. Species of Candida, other than C. albicans are normal flora of cutaneous and mucocutaneous surfaces and are only rarely incriminated as agents of clinical disease (1). Of the many media used for isolating and differentiating Candida, Pagano Levin Base (M1390) employes TTC (Triphenyl Tetrazolium Chloride) as an indicator. Harold and Snyder (2) observed that the TTC used greatly retards the growth of some Candida species, while completely inhibiting the rest. Therefore to overcome this difficulty, they formulated Candida BCG Agar, which employs bromocresol green instead of TTC as the indicator. Candida BCG Agar Base is used to obtain pure yeast colonies from mixed cultures on the basis of colony morphology (3, 4). Candida BCG HiVeg™ Agar Base is prepared by using vegetable peptones in place of animal based peptones which make the media free of BSE/TSE risks. HiVeg™ peptone along with yeast extract and dextrose serve as sources of essential nutrients, amino acids and vitamins. Dextrose also serves as a source of energy by being the fermentable carbohydrate. Bromocresol green is non-toxic indicator incorporated to visualize the fermentation reaction. Selectivity is obtained by the addition of neomycin. Neomycin is incorporated to inhibit gram-negative bacteria and some gram-positive bacteria. Neomycin is an aminoglycoside antibiotic that is active against aerobic and facultatively anaerobic gram-negative bacteria and certain gram-positive bacteria. Bromocresol green is the indicator. Acid production due to fermentation lowers the pH of the medium and subsequently the colour of medium changes to yellow, indicated by yellow zones around the dextrose-fermenting colonies. C. albicans appears as blunt conical colonies with smooth edges and yellow to blue green colour. Other Candida species appear as smooth to rough colonies, with either convex or cone shaped colonies. (5). Standard methods should be followed for inoculating the plates of Candida BCG HiVeg™ Agar Base. Presumptive Candida colonies should be further identified by gram staining, biochemical and serological testing (6,7,8).

Type of specimen

Please add specimen

Specimen Collection and Handling:

After use, contaminated materials must be sterilized by autoclaving before discarding.

Warning and Precautions :

Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling specimens. Safety guidelines may be referred in individual safety data sheets.

Limitations :

Standard methods should be followed for inoculating the plates of Candida BCG Agar.
Presumptive Candida colonies should be further identified by gram staining, biochemical and serological testing (6,7,8).

Performance and Evaluation

Performance of the medium is expected when used as per the direction on the label within the expiry period when stored at recommended temperature.

Quality Control

Appearance
Cream to light green homogeneous free flowing powder

Gelling
Firm, comparable with 1.5% Agar gel

Colour and Clarity of prepared medium
Bluish green coloured, clear to slightly opalescent gel forms in Petri plates

Reaction
Reaction of 6.6% w/v aqueous solution at 25°C. pH: 6.1±0.2

pH
5.90-6.30

Cultural Response
Cultural characteristics observed with added sterile Neomycin (500 mcg/ml of medium) after an incubation at 25-30°C for 24-48 hours.

Organism	Inoculum (CFU)	Growth	Recovery	Colour of medium
Candida albicans ATCC 10231 (00054*)	50-100	good-luxuriant	>=50%	yellow
Candida glabrata ATCC 15126	50-100	good-luxuriant	>=50%	yellow
Candida kruisei ATCC 24408	50-100	good-luxuriant	>=50%	yellow
Candida tropicalis ATCC 1369	50-100	good-luxuriant	>50%	yellow
Escherichia coli ATCC 25922 (00013*)	>=10⁴	inhibited	0%
Staphylococcus aureus subsp. aureus ATCC 25923 (00034*)	>=10⁴	inhibited	0%

Key: *Corresponding WDCM numbers.

Storage and Shelf Life

Store between 10-30°C in a tightly closed container and the prepared medium at 20-30°C. Use before expiry date on the label. On opening, product should be properly stored dry, after tightly capping the bottle in order to prevent lump formation due to the hygroscopic nature of the product. Improper storage of the product may lead to lump formation. Store in dry ventilated area protected from extremes of temperature and sources of ignition. Seal the container tightly after use. Product performance is best if used within stated expiry period.

Disposal

User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow established laboratory procedures in disposing of infectious materials and material that comes into contact with sample must be decontaminated and disposed of in accordance with current laboratory techniques (9,10).

Product Information

More Information
Product Name	Candida BCG HiVeg™ Agar Base
SKU	MV355
Product Type	HiVeg™
Physical Form	Powder
Origin	Animal Free (Veg)
Packaging type	HDPE
References	1. Konemann E. W., Allen S. D., Janda M. W., Schreckenberger P.C, Winn C. W. Jr., 1992, Colour Atlas and Text book ofDiagnostic Microbiology,4th Ed. J. B. Lippincott Company. 2.Harold and Snyder, 1968, Personal communication. 3.Haley L. D., and Callaway C. S., 1978, Laboratory Methods in Medical Mycology, 4th Ed., U.S. Government PrintingOffice, Washington, D.C. 4.Haley L. D., Trandel J., Coyle M. B. and Sherris J. C., 1980, Practical Methods for Culture and Identification of Fungi inthe Clinical Microbiology Laboratory, CUMITECH II, Washington D.C.: American Society For Microbiology 5.Atlas R. M., 2004, Handbook of Microbiological Media, 3rd Ed., CRC Press. 6.Kwon-Chung and Bennett, 1992, Medical Mycology, Lea & Febiger, Philadelphia, Pa. 7.Forbes B. A., Sahm D. F. and Weissfeld A. S., Bailey & Scotts Diagnostic Microbiology, 10th Ed., 1998, Mosby, Inc., St.Louis, Mo. 8.Murray P. R., Baron J. H., Pfaller M. A., Jorgensen J. H. and Yolken R. H., (Ed.). 2003, Manual of Clinical Microbiology,8th Ed., American Society for Microbiology, Washington, D.C. 9.Isenberg, H.D. Clinical Microbiology Procedures Handbook 2nd Edition10.Jorgensen, J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015) Manual of Clinical Microbiology, 11th Edition. Vol. 1.
Customized Product Available	No